Key result
Patients with peripheral arterial events exhibit poor premorbid control despite known vascular disease and treatable risks.
Why the study?
The clinical burden of peripheral arterial events is substantial, and despite known vascular disease and treatable risk factors, premorbid control remains poor.
Premorbid control of treatable risk factors is poor in patients who suffer ischemic peripheral arterial events, despite known vascular disease.
Highlights opportunities to improve premorbid risk factor control in known vascular disease; hypothesis-generating for whether better management reduces peripheral arterial events.
The clinical burden of peripheral arterial events is substantial. Although the vast majority of patients have known vascular disease in other territories and multiple treatable risk factors, premorbid control is poor.
No takes yet. Share an insight, caveat, or question.
Howard et al. (2015) studied this question. Patients with peripheral arterial events exhibit poor premorbid control despite the vast majority having known vascular disease in other territories and multiple treatable risk factors.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: